1,3,5-triaza-7-phosphaadamantane has been researched along with iridium in 2 studies
Studies (1,3,5-triaza-7-phosphaadamantane) | Trials (1,3,5-triaza-7-phosphaadamantane) | Recent Studies (post-2010) (1,3,5-triaza-7-phosphaadamantane) | Studies (iridium) | Trials (iridium) | Recent Studies (post-2010) (iridium) |
---|---|---|---|---|---|
44 | 0 | 33 | 3,270 | 25 | 1,766 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erlandsson, M; Gonsalvi, L; Ienco, A; Peruzzini, M | 1 |
Nordlander, E; Quintero, MAS; Smith, GS; Stringer, T; Wiesner, L | 1 |
2 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and iridium
Article | Year |
---|---|
Diastereomerically enriched analogues of the water-soluble phosphine PTA. Synthesis of phenyl(1,3,5-triaza-7-phosphatricyclo[3.3.1.1(3,7)]dec-6-yl)methanol (PZA) and the sulfide PZA(S) and X-ray crystal structures of the oxide PZA(O) and [Cp*IrCl(2)(PZA)]
Topics: Adamantane; Crystallography, X-Ray; Heterocyclic Compounds, 3-Ring; Iridium; Lithium; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Oxides; Phosphines; Salts; Solubility; Stereoisomerism; Sulfides; Water | 2008 |
Evaluation of PTA-derived ruthenium(II) and iridium(III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite.
Topics: Adamantane; Animals; Antimalarials; Chloroquine; Coordination Complexes; Drug Resistance; Iridium; Organophosphorus Compounds; Plasmodium falciparum; Quinolines; Ruthenium | 2019 |